130 related articles for article (PubMed ID: 31586772)
21. A randomized double-blind placebo-controlled trial of treatment as usual plus exogenous slow-release melatonin (6 mg) or placebo for sleep disturbance and depressed mood.
Serfaty MA; Osborne D; Buszewicz MJ; Blizard R; Raven PW
Int Clin Psychopharmacol; 2010 May; 25(3):132-42. PubMed ID: 20195158
[TBL] [Abstract][Full Text] [Related]
22. Simvastatin versus atorvastatin for improving mild to moderate depression in post-coronary artery bypass graft patients: A double-blind, placebo-controlled, randomized trial.
Abbasi SH; Mohammadinejad P; Shahmansouri N; Salehiomran A; Beglar AA; Zeinoddini A; Forghani S; Akhondzadeh S
J Affect Disord; 2015 Sep; 183():149-55. PubMed ID: 26005776
[TBL] [Abstract][Full Text] [Related]
23. The Healthy Heart-Mind Trial: Randomized Controlled Trial of Melatonin for Prevention of Delirium.
Ford AH; Flicker L; Kelly R; Patel H; Passage J; Wibrow B; Anstey M; Edwards M; Almeida OP
J Am Geriatr Soc; 2020 Jan; 68(1):112-119. PubMed ID: 31595489
[TBL] [Abstract][Full Text] [Related]
24. Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Trial.
Earley WR; Guo H; Németh G; Harsányi J; Thase ME
Psychopharmacol Bull; 2018 Jun; 48(4):62-80. PubMed ID: 30618475
[TBL] [Abstract][Full Text] [Related]
25. Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial.
Kaneriya SH; Robbins-Welty GA; Smagula SF; Karp JF; Butters MA; Lenze EJ; Mulsant BH; Blumberger D; Anderson SJ; Dew MA; Lotrich F; Aizenstein HJ; Diniz BS; Reynolds CF
JAMA Psychiatry; 2016 Apr; 73(4):329-36. PubMed ID: 26963689
[TBL] [Abstract][Full Text] [Related]
26. BDNF val66met polymorphism and depressive disorders in patients with acute coronary syndrome.
Kang HJ; Bae KY; Kim SW; Shin IS; Hong YJ; Ahn Y; Jeong MH; Yoon JS; Kim JM
J Affect Disord; 2016 Apr; 194():1-8. PubMed ID: 26795846
[TBL] [Abstract][Full Text] [Related]
27. Lisdexamfetamine dimesylate augmentation for adults with major depressive disorder and inadequate response to antidepressant monotherapy: Results from 2 phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
Richards C; McIntyre RS; Weisler R; Sambunaris A; Brawman-Mintzer O; Gao J; Geibel B; Dauphin M; Madhoo M
J Affect Disord; 2016 Dec; 206():151-160. PubMed ID: 27474961
[TBL] [Abstract][Full Text] [Related]
28. Effect of Depression Screening After Acute Coronary Syndromes on Quality of Life: The CODIACS-QoL Randomized Clinical Trial.
Kronish IM; Moise N; Cheung YK; Clarke GN; Dolor RJ; Duer-Hefele J; Margolis KL; St Onge T; Parsons F; Retuerto J; Thanataveerat A; Davidson KW
JAMA Intern Med; 2020 Jan; 180(1):45-53. PubMed ID: 31633746
[TBL] [Abstract][Full Text] [Related]
29. Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents.
Cox GR; Callahan P; Churchill R; Hunot V; Merry SN; Parker AG; Hetrick SE
Cochrane Database Syst Rev; 2012 Nov; 11():CD008324. PubMed ID: 23152255
[TBL] [Abstract][Full Text] [Related]
30. Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial.
Schaefer M; Sarkar R; Knop V; Effenberger S; Friebe A; Heinze L; Spengler U; Schlaepfer T; Reimer J; Buggisch P; Ockenga J; Link R; Rentrop M; Weidenbach H; Fromm G; Lieb K; Baumert TF; Heinz A; Discher T; Neumann K; Zeuzem S; Berg T
Ann Intern Med; 2012 Jul; 157(2):94-103. PubMed ID: 22801672
[TBL] [Abstract][Full Text] [Related]
31. Predictors of depressive disorder following acute coronary syndrome: Results from K-DEPACS and EsDEPACS.
Kang HJ; Stewart R; Bae KY; Kim SW; Shin IS; Hong YJ; Ahn Y; Jeong MH; Yoon JS; Kim JM
J Affect Disord; 2015 Aug; 181():1-8. PubMed ID: 25913538
[TBL] [Abstract][Full Text] [Related]
32. Adjunctive Lanicemine (AZD6765) in Patients with Major Depressive Disorder and History of Inadequate Response to Antidepressants: A Randomized, Placebo-Controlled Study.
Sanacora G; Johnson MR; Khan A; Atkinson SD; Riesenberg RR; Schronen JP; Burke MA; Zajecka JM; Barra L; Su HL; Posener JA; Bui KH; Quirk MC; Piser TM; Mathew SJ; Pathak S
Neuropsychopharmacology; 2017 Mar; 42(4):844-853. PubMed ID: 27681442
[TBL] [Abstract][Full Text] [Related]
33. Effects of vitamin D supplementation on depressive symptoms in type 2 diabetes mellitus patients: Randomized placebo-controlled double-blind clinical trial.
Omidian M; Mahmoudi M; Abshirini M; Eshraghian MR; Javanbakht MH; Zarei M; Hasani H; Djalali M
Diabetes Metab Syndr; 2019; 13(4):2375-2380. PubMed ID: 31405646
[TBL] [Abstract][Full Text] [Related]
34. Pioglitazone adjunctive therapy for depressive episode of bipolar disorder: a randomized, double-blind, placebo-controlled trial.
Zeinoddini A; Sorayani M; Hassanzadeh E; Arbabi M; Farokhnia M; Salimi S; Ghaleiha A; Akhondzadeh S
Depress Anxiety; 2015 Mar; 32(3):167-73. PubMed ID: 25620378
[TBL] [Abstract][Full Text] [Related]
35. Female Psychological Adjustment Following an Acute Coronary Syndrome.
Prata J; Martins AQ; Ramos S; Rocha-Gonçalves F; Coelho R
Acta Med Port; 2017 May; 30(5):373-380. PubMed ID: 28865501
[TBL] [Abstract][Full Text] [Related]
36. Predictive value of homocysteine for depression after acute coronary syndrome.
Kang HJ; Stewart R; Bae KY; Kim SW; Shin IS; Kang H; Moon WJ; Hong YJ; Ahn Y; Jeong MH; Yoon JS; Kim JM
Oncotarget; 2016 Oct; 7(42):69032-69040. PubMed ID: 27626182
[TBL] [Abstract][Full Text] [Related]
37. Depressive and anxiety symptoms and illness perception among patients with acute coronary syndrome.
Zou H; Chair SY; Zhang C; Bao A
J Adv Nurs; 2023 Jul; 79(7):2632-2642. PubMed ID: 36896878
[TBL] [Abstract][Full Text] [Related]
38. Effects of melatonin administration on mental health parameters, metabolic and genetic profiles in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial.
Shabani A; Foroozanfard F; Kavossian E; Aghadavod E; Ostadmohammadi V; Reiter RJ; Eftekhar T; Asemi Z
J Affect Disord; 2019 May; 250():51-56. PubMed ID: 30831541
[TBL] [Abstract][Full Text] [Related]
39. Clinical impact of melatonin on breast cancer patients undergoing chemotherapy; effects on cognition, sleep and depressive symptoms: A randomized, double-blind, placebo-controlled trial.
Palmer ACS; Zortea M; Souza A; Santos V; Biazús JV; Torres ILS; Fregni F; Caumo W
PLoS One; 2020; 15(4):e0231379. PubMed ID: 32302347
[TBL] [Abstract][Full Text] [Related]
40. I-CARE randomized clinical trial integrating depression and acute coronary syndrome care in low-resource hospitals in China: Design and rationale.
Li S; Blumenthal JA; Shi C; Millican D; Li X; Du X; Patel A; Gao P; Delong E; Maulik PK; Gao R; Yu X; Wu Y
Am Heart J; 2018 Aug; 202():109-115. PubMed ID: 29933147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
